Adcentrx Therapeutics Doses First Patient in Phase 1b Expansion Cohorts with ADRX-0706 Nectin-4 ADC
Alex Nye
Press Releases
Adcentrx Therapeutics  
December 2, 2024

Adcentrx Therapeutics Doses First Patient in Phase 1b Expansion Cohorts with ADRX-0706 Nectin-4 ADC

Marks successful completion of Phase 1a dose escalationPhase 1b dose expansion results expected 4Q 2025

logo salamanca press

Salamanca Press

Local & Social